Variant report

Variant	esv3499027
Chromosome Location	chr6:44511436-44515867
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr6:44510267..44512106-chr6:44515045..44516562,2	K562	blood:
2	chr6:44504867..44507271-chr6:44510365..44512110,2	K562	blood:
3	chr6:44510267..44512106-chr6:44515045..44516562,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AARS2-2	chr6:44513902-44514193	NONHSAT112964

Extended variants
information (count: 163 )
Associated
traits (count: 96 )

Variant overlapped rSNPs/rCNVs (count:163 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs528396861	chr6:44511465-44511466	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs546470894	chr6:44511603-44511604	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs117767651	chr6:44511612-44511613	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs553423658	chr6:44511613-44511614	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs139343542	chr6:44511632-44511633	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs569269125	chr6:44511664-44511665	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs536218846	chr6:44511689-44511690	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs60013009	chr6:44511703-44511704	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs55739205	chr6:44511736-44511737	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs374273007	chr6:44511749-44511750	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs540837146	chr6:44511750-44511751	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs565410864	chr6:44511754-44511755	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs146565037	chr6:44511792-44511793	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs551497345	chr6:44511819-44511820	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs141220811	chr6:44511827-44511828	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs373232370	chr6:44511828-44511829	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs577396024	chr6:44511909-44511910	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs544759555	chr6:44511918-44511919	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs116261819	chr6:44511927-44511928	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs575431248	chr6:44512025-44512026	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs542596171	chr6:44512056-44512057	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs571152867	chr6:44512113-44512114	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs145026818	chr6:44512190-44512191	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs554028896	chr6:44512218-44512219	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs146784595	chr6:44512288-44512289	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs149121203	chr6:44512303-44512304	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs376915214	chr6:44512333-44512334	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs544535549	chr6:44512339-44512340	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs563198072	chr6:44512357-44512358	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs371650628	chr6:44512387-44512388	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs71564613	chr6:44512398-44512399	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs115362327	chr6:44512415-44512416	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs550524735	chr6:44512417-44512418	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs568963946	chr6:44512474-44512475	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs536357030	chr6:44512485-44512486	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs548166196	chr6:44512490-44512491	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs185369078	chr6:44512518-44512519	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs534204045	chr6:44512527-44512528	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs559236014	chr6:44512571-44512572	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs577481328	chr6:44512624-44512625	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs533534410	chr6:44512675-44512676	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs114564970	chr6:44512686-44512687	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs556481906	chr6:44512697-44512698	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs575367807	chr6:44512702-44512703	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs148252825	chr6:44512754-44512755	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs190662755	chr6:44512758-44512759	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs6458394	chr6:44512783-44512784	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs141240804	chr6:44512789-44512790	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs180839807	chr6:44512833-44512834	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs532310706	chr6:44512882-44512883	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:96)

Disease	PMID	Source
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Melanoma	18172304	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Hepatocellular carcinoma	16750200	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Osteosarcoma	16790693	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21720365	CNVD
Osteosarcoma	21197465	CNVD
Gastric cancer	24379144	CNVD
Neuroblastoma	18923191	CNVD
abnormal development	18461090	CNVD
Breast cancer	17603634	CNVD
Breast cancer	21364760	CNVD
Colorectal cancer	16790693	CNVD
Congenital adrenal hyperplasia	18478071	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Systemic lupus erythematosus	19287148	CNVD
Colorectal cancer	19359472	CNVD
Multiple myeloma	16616336	CNVD
Chordoma	18071362	CNVD
Follicular lymphoma	16790693	CNVD
Osteosarcoma	19286668	CNVD
Neurocytoma	17123091	CNVD
Myelofibrosis	22110671	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Ovarian cancer	20844748	CNVD
lymphocytic leukemia	21291569	CNVD
Cancer	20164919	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Gastrointestinal stromal cancer	20818650	CNVD

Chromatin state (count:27 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:44509200-44511600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr6:44509800-44513000	Weak transcription	H9 Cell Line	embryonic stem cell
3	chr6:44510200-44511600	Enhancers	Psoas Muscle	Psoas
4	chr6:44510600-44511600	Enhancers	Ovary	ovary
5	chr6:44511000-44511600	Enhancers	iPS-20b Cell Line	embryonic stem cell
6	chr6:44511000-44511600	Enhancers	Skeletal Muscle Male	skeletal muscle
7	chr6:44511000-44513000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
8	chr6:44511000-44516000	Weak transcription	HSMMtube	muscle
9	chr6:44511000-44516800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr6:44511200-44511600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
11	chr6:44511200-44511800	Weak transcription	HUES64 Cell Line	embryonic stem cell
12	chr6:44511400-44512200	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
13	chr6:44511400-44512800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
14	chr6:44511600-44512200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
15	chr6:44511600-44512200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
16	chr6:44511600-44512600	Weak transcription	Skeletal Muscle Male	skeletal muscle
17	chr6:44511600-44512800	Weak transcription	Psoas Muscle	Psoas
18	chr6:44511800-44512000	Enhancers	HUES64 Cell Line	embryonic stem cell
19	chr6:44512200-44512400	Enhancers	iPS-20b Cell Line	embryonic stem cell
20	chr6:44512200-44512600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
21	chr6:44512600-44513000	Enhancers	Skeletal Muscle Male	skeletal muscle
22	chr6:44512800-44513000	Enhancers	Psoas Muscle	Psoas
23	chr6:44512800-44513400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
24	chr6:44513000-44513200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
25	chr6:44513000-44513200	Weak transcription	Psoas Muscle	Psoas
26	chr6:44513000-44513600	Enhancers	H9 Cell Line	embryonic stem cell
27	chr6:44513400-44523800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links